eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Cosmetic Surgery

Blepharoplasty, Transconjunctival Approach

Author: Suzanne K Doud Galli, MD, PhD, Consulting Staff, Cosmetic Facial Surgery, Private Practice
Coauthor(s): Philip J Miller, MD, FACS, Assistant Professor, Department of Otolaryngology, Division of Facial Plastic and Reconstructive Surgery, New York University School of Medicine
Contributor Information and Disclosures

Updated: Jan 8, 2009

Introduction

Lower eyelid blepharoplasty is often the treatment for patients who have bags or puffiness under the eyes. This deformity is frequently a result of pseudoherniation of the orbital fat. Skin laxity and rhytides may contribute to the overall perception of the deformity. Blepharoplasty rejuvenates and restores the lower lid area. Traditionally, the anterior transcutaneous approach is used for this procedure. This technique provides excellent exposure to the orbital fat, and the resultant scar is minimal. Unfortunately, the approach is associated with many complications.

Lower eyelid malposition is a feared complication after lower lid blepharoplasty and may be associated with scleral show and ectropion of various degrees. These complications tend to limit the success of the transcutaneous blepharoplasty technique. To this end, the use of a posterior transconjunctival technique has been explored. By avoiding scarring at the anterior lamella and lower eyelid septum, retraction of the eyelid and ectropion can be avoided. Accordingly, the posterior transconjunctival approach has gained in popularity and acceptance. The transconjunctival incision through the fornix seems to offer less risk for postoperative lid malposition and provides for the best exposure to the orbital fat.

History of the Procedure

Tessier reported his use of the transconjunctival approach for craniofacial procedures in the 1970s.1 He had been applying this approach for congenital abnormalities and trauma for almost 20 years when he presented his findings. In the 1920s, Bourget first described the transconjunctival approach in the French literature as a method for removing herniated orbital fat.2 Tessier adapted the technique to approach the orbital floor without leaving a visible scar. He found the standard periorbital incisions to be limited to specific maneuvers and theorized that the transconjunctival technique was truly the most logical approach to the orbital walls.

Transconjunctival approaches to the lower eyelid have become very popular. In combination with other techniques, the application can be expanded to address skin laxity and rhytides as well as pseudoherniated fat.

Problem

The goal of blepharoplasty of the lower lid is to rejuvenate and thus restore the eyelid. This is achieved with special attention to lateral canthus definition and to eyelid position and function. Excess fat (pseudoherniated orbital fat) is removed, and excess skin is then addressed. Excess fat in this region may arise from a hereditary pseudoherniation of the fat or from the effects of aging. Additionally, systemic diseases, including allergies, cardiac or renal disease, liver cirrhosis, and hyperthyroidism, may contribute to puffiness around the lower eyelid.

A genetic condition known as blepharochalasis is another potential disorder leading to this deformity. Blepharochalasis is a familial disorder that results in chronic eyelid edema, which can progress to localized tissue breakdown and fat herniation. Clearly, these conditions are separate from the pseudoherniation observed in the typical patient evaluated for cosmetic blepharoplasty, and they must therefore be excluded.

The ideal patient is young and has excess pseudoherniated fat but minimal skin laxity. Older patients may benefit from the transconjunctival approach combined with a pinch excision of excess skin or a resurfacing technique such as laser resurfacing or deep chemical peel.

Pathophysiology

As humans age, the orbital septum loses its structural integrity and consequently fails to contain the orbital fat. The supporting structures of the orbit also become lax, allowing settling of the globe, which contributes to fat protrusion. Although the fat remains posterior to the orbital septum, the septum/fat complex bulges forward, giving the illusion of herniated fat (hence the term pseudoherniation). The transconjunctival approach delivers the fat without disrupting the orbital septum and removes the excess fat.

Presentation

Candidates for blepharoplasty typically present with fat herniation and are unhappy with the bags, puffiness, or dark circles under their eyes.

Indications

Assess candidates for blepharoplasty by evaluating pseudoherniated fat, excess eyelid skin, skin laxity, and rhytides. Because the transconjunctival approach is best for removal of pseudoherniated fat, patients who have fat pseudoherniation without additional skin laxity or orbicularis oculi hypertrophy are the best candidates.

Because the technique has a lower risk of resultant scleral show and eyelid retraction (as with the transcutaneous approach), patients with pseudoproptosis and lower eyelid bulges are eligible for the transconjunctival approach. Additionally, patients with retracted eyelids from Graves disease are also good candidates for transconjunctival blepharoplasty.

The transconjunctival approach is a better option in patients who express concerns about scarring with the transcutaneous approach. Although the resultant transcutaneous scar is almost imperceptible, depigmentation at the scar line sometimes occurs in darker-skinned individuals. The transconjunctival approach obviates this possibility.

Relevant Anatomy

The lower eyelid is composed of 3 lamellae. At the level of the tarsus, the posterior lamella consists of the conjunctiva and the tarsus. Inferior to the tarsus, the posterior lamella is composed of conjunctiva, the retractor muscle, and the capsulopalpebral fascia. The middle lamella fuses with the posterior lamella at the tarsal plate and is composed of the orbital septum. The anterior lamella is the orbicularis oculi muscle and overlying skin. The orbital septum is a central component of the lower eyelid. The orbital septum inserts along the inferior aspect of the tarsus and extends inferiorly to its insertion at the arcus marginalis at the orbital rim. The orbital septum confines the fat pads. If the septum is weak, either congenitally or from aging, pseudoherniation of the orbital fat can begin.

Three fat compartments apparently exist: lateral, middle, and medial. Although these compartments are more practical than anatomical, the medial fat pad is separated from the middle pad by the inferior oblique muscle and the arcuate expanse dividing the middle from the lateral fat pad. The medial fat pad is whiter than the middle and lateral pads. The middle fat pad is more yellowish and is often removed in pieces, whereas the medial and lateral pads are often removed intact. In repose, the position of the lower eyelid conjunctiva is vertical at the lid margin and horizontal at the fornix. The average depth of the fornix from the lid margin is 12-14 mm, and the average height of the tarsal plate is approximately 4.5 mm.

Contraindications

Transconjunctival blepharoplasty is a technique that best addresses pseudoherniated orbital fat. In the patient with minimal fat pseudoherniation, this approach may not be best. In patients with significant skin laxity and redundancy, and in patients with hypertrophic orbicularis oculi muscle, the transconjunctival approach can offer little benefit unless combined with an adjunct procedure.

As with all blepharoplasty techniques, transconjunctival blepharoplasty is relatively contraindicated in the patient with severe lower eyelid laxity unless accompanied with lid-tightening procedures.

More on Blepharoplasty, Transconjunctival Approach

Overview: Blepharoplasty, Transconjunctival Approach
Workup: Blepharoplasty, Transconjunctival Approach
Treatment: Blepharoplasty, Transconjunctival Approach
Follow-up: Blepharoplasty, Transconjunctival Approach
Multimedia: Blepharoplasty, Transconjunctival Approach
References

References

  1. Tessier P. The conjunctival approach to the orbital floor and maxilla in congenital malformation and trauma. J Maxillofac Surg. Mar 1973;1(1):3-8. [Medline].

  2. Bourget J. Notre traitement chirurgical de "poches sous les yeuz" sans cicatrice. Archives Franco-Belges de Chirurgie. 1928;31:133-137.

  3. Asken S. The preseptal and the retroseptal approaches in transconjunctival blepharoplasty. J Dermatol Surg Oncol. Dec 1992;18(12):1110-6. [Medline].

  4. Dodenhoff TG. Transconjunctival blepharoplasty: further applications and adjuncts. Aesthetic Plast Surg. Nov-Dec 1995;19(6):511-7. [Medline].

  5. Doxanas MT. Minimally invasive lower eyelid blepharoplasty. Ophthalmology. Aug 1994;101(8):1327-32. [Medline].

  6. Fedok FG, Perkins SW. Transconjunctival blepharoplasty. Facial Plast Surg. Apr 1996;12(2):185-95. [Medline].

  7. Ghabrial R, Lisman RD, Kane MA, et al. Diplopia following transconjunctival blepharoplasty. Plast Reconstr Surg. Sep 1998;102(4):1219-25. [Medline].

  8. Gilbert SE. Transconjunctival blepharoplasty with chemoexfoliation. Ann Plast Surg. Jul 1996;37(1):24-9. [Medline].

  9. Ginsbach G. Periorbital aesthetic surgery with the KTP laser. Aesthetic Plast Surg. Nov-Dec 1995;19(6):505-9. [Medline].

  10. Goldberg RA, Lessner AM, Shorr N, et al. The transconjunctival approach to the orbital floor and orbital fat. A prospective study. Ophthal Plast Reconstr Surg. 1990;6(4):241-6. [Medline].

  11. Gubisch W. [The value of various techniques for esthetic correction of the lower eyelid]. Handchir Mikrochir Plast Chir. Mar 1999;31(2):113-20. [Medline].

  12. Holt JE, Holt GR. Blepharoplasty. Indications and preoperative assessment. Arch Otolaryngol. Jun 1985;111(6):394-7. [Medline].

  13. Kikkawa DO, Kim JW. Lower-eyelid blepharoplasty. Int Ophthalmol Clin. Summer 1997;37(3):163-78. [Medline].

  14. Nassif PS. Lower blepharoplasty: transconjunctival fat repositioning. Facial Plast Surg Clin North Am. Nov 2005;13(4):553-9, vi. [Medline].

  15. Palmer FR 3rd, Rice DH, Churukian MM. Transconjunctival blepharoplasty. Complications and their avoidance: a retrospective analysis and review of the literature. Arch Otolaryngol Head Neck Surg. Sep 1993;119(9):993-9. [Medline].

  16. Soll SM, Lisman RD, Charles NC, et al. Pyogenic granuloma after transconjunctival blepharoplasty: a case report. Ophthal Plast Reconstr Surg. Dec 1993;9(4):298-301. [Medline].

  17. Tebbetts JB. Blepharoplasty. A refined technique emphasizing accuracy and control. Clin Plast Surg. Apr 1992;19(2):329-49. [Medline].

  18. Yousif NJ, Sonderman P, Dzwierzynski WW, et al. Anatomic considerations in transconjunctival blepharoplasty. Plast Reconstr Surg. Nov 1995;96(6):1271-6; discussion 1277-8. [Medline].

  19. Zarem HA, Resnick JI. Expanded applications for transconjunctival lower lid blepharoplasty. Plast Reconstr Surg. Aug 1991;88(2):215-20; discussion 221. [Medline].

Further Reading

Keywords

blepharoplasty, eyelid surgery, transconjunctival lower lid blepharoplasty, lower eyelid blepharoplasty, lower eyelid surgery, pseudoherniation, cosmetic blepharoplasty, herniated orbital fat, pseudoherniated orbital fat, rhytid, orbital fat, festoons, bags, puffiness, skin laxity, scleral show, ectropion, blepharochalasis, orbicularis oculi hypertrophy, pseudoproptosis, eyelid, cosmetic surgery

Contributor Information and Disclosures

Author

Suzanne K Doud Galli, MD, PhD, Consulting Staff, Cosmetic Facial Surgery, Private Practice
Suzanne K Doud Galli, MD, PhD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Rhinologic Society, and Triological Society
Disclosure: Nothing to disclose.

Coauthor(s)

Philip J Miller, MD, FACS, Assistant Professor, Department of Otolaryngology, Division of Facial Plastic and Reconstructive Surgery, New York University School of Medicine
Philip J Miller, MD, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American College of Surgeons, American Medical Association, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Jaime R Garza, MD, DDS, FACS, Consulting Staff, Private Practice
Jaime R Garza, MD, DDS, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Medical Association, American Society for Aesthetic Plastic Surgery, American Society of Maxillofacial Surgeons, Texas Medical Association, and Texas Society of Plastic Surgeons
Disclosure: Allergan Honoraria Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Keith A LaFerriere, MD, Clinical Professor, Fellowship Director, Department of Surgery, Division of Otolaryngology, University of Missouri at Columbia
Keith A LaFerriere, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, and Missouri State Medical Association
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.